Pharmaceutical Executive October 21, 2024
The latest news for pharma industry insiders.
The Rise of GLP-1 Drugs and the Challenges of Proper Disposal
With great power comes great responsibility. In this case, tackling these obstacles is vital to making sure that the positives of GLP-1s are not outweighed by the downfalls of improper waste disposal.
In the Real World, People Do Not Stick With GLP-1s for Weight Loss | AMCP Nexus 2024
Only 15% of those who start a glucagon-like peptide 1 (GLP-1) for weight loss are still taking it two years later according to Prime Therapeutics’ real-world evidence, says Ben Urick, Pharm.D., Ph.D., a health outcomes researcher for the pharmacy benefit manager.
What’s at Stake in a Strained Microsoft-OpenAI Partnership
The alliance between the...
Today's Sponsors
Today's Sponsor